Hetero Biopharma launched Derise in Sri Lanka- Rise of first Darbepoetin in Sri Lanka
We are pleased to inform you that Hetero Biopharma – the Biologics arm of Hetero Group has recently launched ‘Derise’ (Darbepoetin Alfa) in Colombo, the capital city of Sri Lanka on 19th Jan 2019.
Witnessing the mega launch program in Ceylon, entire business team of Hetero Biopharma Dr. Jayapala Reddy A.V (AVP & Global Head- Biologics Business, Mr. Krishna Kishore (DGM- Global Biologics Business), Dr. Praveen Shetty (DGM – Biologics Medico-Marketing & CT), Mr. Vinod (Manager – Global Biologics Business), Mr. Ramesh Reddy Y (Manager – Global Biologics Business) Mr. Sharath ( Asst. Manager – Marketing), Mr. Pavan (Officer Global Biologics Business) and technical team from Hetero Biopharma plant spearheaded by Dr. Bala Reddy ( AVP & Plant Head) Mr. Balaji (Regulatory Head) & Mr. Prashanth (Asst. Manager- Supply Chain) have attended the launch program.
The event was attended by KOLs of various departments viz Nephrology, Haematology and Oncology, along with sales and marketing team Hetero business partner GS Healthcare based at Sri Lanka. The launch has created a platform to share the experience of Darbepoetin over conventional treatment options in addressing treatment options. AV for this program with stage perform artist has been made which is highly appreciated across the attendees.
Dr. Darshan Rangaswamy (Deputy HOD, Associate Professor- Nephrology- KMC Manipal Hospitals, India addressed the audience as a key opinion leader (KOL) on behalf of Hetero Biopharma with a session on “Role of Darbepoetin in the treatment of CKD associated anaemia” while Dr. Praveen Shetty (DGM, Global Clinical Strategy & Medico Marketing) presented “Clinical trials of Darbepoetin in CKD and CIA associated anaemia”.
Dr. Jayapala Reddy share the overall vision of Hetero and Hetero Biopharma emphasizing the efforts of Hetero Biopharma in reaching every needy patient across the globe with our HBP’s corporate philosophy of REACH. He further stressed on our commitment of creating awareness on complex biosimilars across emerging markets under Knowledge Beyond Boarders (KBB). Dr. Bala Reddy highlighted the company’s efforts in bringing complex and life-saving drugs affordable to all needy patients across the globe and concluded the program with vote of thanks.
Our business partners in Sri Lanka George Stewart Health (GSH) a group company of DIVAASA is represented by Mr. Amara Sekhara (Managing Director), Mr. Eran (Director – GSH) Mr. Lenin (Sales & Marketing Head), Mr. Vinoj (Manager- Sales) and team.